HLA Typing Market
With a projected compound annual growth rate (CAGR) of 5.6% from 2022 to 2029, the HLA Typing Market is on track to achieve a total value of $1.9 billion by 2029.n
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
TOP HLA TYPING MARKET COMPANIES TO WATCH
HLA Typing Market 2022-2029 According to Meticulous Research, the HLA Typing Market is anticipated to grow at a CAGR of 5.6% from 2022 to 2029, reaching $1.9 billion by 2029. The market includes consumables, instruments, software, and services, with growth driven by the increasing volume of organ transplants and technological advancements in molecular assays. Enhanced awareness of organ donation also presents new growth opportunities. Here are the top 10 companies operating in the HLA Typing Market: Becton, Dickinson and Company (BD) (U.S.) Becton, Dickinson and Company (BD), founded in 1897 and headquartered in New Jersey, is a major player in the medical device and diagnostics industry. The BD Life Sciences segment, particularly the Biosciences unit, provides HLA typing products including antibodies and immunofluorescence test kits. BD operates manufacturing facilities in various countries, including Brazil, China, and India. Thermo Fisher Scientific Inc. (U.S.) Thermo Fisher Scientific, founded in 2006 in Massachusetts, offers life sciences research and diagnostic solutions. Its Specialty Diagnostics segment includes Transplant Diagnostics, which provides HLA typing assays using serological and molecular techniques. Thermo Fisher has a significant international presence with facilities in countries such as China, Denmark, and Japan. Illumina, Inc. (U.S.) Illumina, established in 1998 and based in California, develops and sells life sciences tools for gene analysis. Its Core Illumina segment offers NGS-based assays and HLA analysis software. Illumina operates in numerous countries, including Germany, Singapore, and South Korea. CareDx, Inc. (U.S.) CareDx, headquartered in California and founded in 1998, provides diagnostic solutions for transplant patients. The company offers a range of HLA typing services and products Page 1 of 3 Meticulous Research| sales@meticulousresearch.com
HLA Typing Market 2022-2029 through its Testing Services and Patient Solutions segments. CareDx has global manufacturing and distribution capabilities, including facilities in Europe and Australia. Genome Diagnostics B.V. (GenDx) (Netherlands) GenDx, based in Utrecht and founded in 2005, is a molecular diagnostics company offering HLA typing and chimerism monitoring services. The company s products are distributed internationally through a network of partners in countries such as China, Brazil, and India. Request For Sample Report Here@ https://www.meticulousresearch.com/request- sample-report/cp_id=5311? Bio-Rad Laboratories, Inc. (U.S.) Bio-Rad, established in 1952 and headquartered in California, provides life science research and clinical diagnostics products. The company s Clinical Diagnostics segment includes HLA typing systems and quality controls. Bio-Rad has a global manufacturing presence in regions such as Europe and Asia. Immucor Inc. (U.S.) Immucor, founded in 1982 and based in Georgia, offers diagnostic products for transfusion and transplantation. Its HLA typing solutions include software and sequencing kits, with products available through an extensive international network. TBG Diagnostics Limited (TDL) (Australia) Founded in 1989 and headquartered in Queensland, TBG Diagnostics develops and manufactures HLA typing kits and diagnostic services. The company maintains R&D and manufacturing facilities in locations including the U.S., China, and Taiwan. BAG Diagnostics GmbH (Germany) BAG Diagnostics, established in 1947 and based in Hesse, Germany, provides HLA typing and blood diagnostic products. The company s global presence includes distribution through partners in several countries. Page 2 of 3 Meticulous Research| sales@meticulousresearch.com
HLA Typing Market 2022-2029 QIAGEN N.V. (Netherlands) QIAGEN, founded in 1984 and headquartered in Venlo, offers a broad range of molecular diagnostic products, including HLA typing kits and software. The company has a wide international footprint with operations in various countries. Browse in Depth Here@ https://www.meticulousresearch.com/product/hla-typing- market-5311? About Meticulous Research Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 Meticulous Research| sales@meticulousresearch.com
